BioMEMS Diagnostics


Privately held Michigan C Corporation (founded April 2022) that develops a handheld point-of-care in‑vitro diagnostic platform comprising a portable analyzer, single‑use multiplexing assay cartridges, mobile connectivity, and diagnostic analytics. The organization emphasizes rapid assay development, validation, and non‑invasive sampling from multiple biofluids.

Industries

N/A


Products

Portable point‑of‑care in‑vitro diagnostic analyzer

A handheld analyzer designed to run single‑use assay cartridges and produce assay results in under three minutes; integrates with mobile phone applications via Bluetooth.

Single‑use multiplexing assay cartridges

Disposable assay cartridges, compact in size, designed to perform multiplexed biomarker measurements from complex biofluids for use with the portable analyzer.


Services

Assay development, verification and validation

Development, verification and validation of custom assays and biomarker panels intended for the company's point‑of‑care platform, with stated timelines measured in months.

Expertise Areas

  • Point‑of‑care in‑vitro diagnostics
  • Assay development and validation
  • Microfluidic / lab‑on‑a‑chip assay cartridge design
  • Diagnostic analytics and signal processing
  • Show More (3)

Key Technologies

  • Point‑of‑care in‑vitro diagnostic platforms
  • Microfluidics / lab‑on‑a‑chip
  • Single‑use multiplexed assay cartridges
  • Bluetooth mobile connectivity
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.